Multidisciplinary Training Program in Pediatric Lung Diseases
小儿肺部疾病多学科培训计划
基本信息
- 批准号:10594441
- 负责人:
- 金额:$ 42.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-07-01 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Project Summary
The goals of the T32 Multidisciplinary Training Program in Pediatric Lung Diseases at Children’s Hospital of
Philadelphia are: (1) To provide a mechanism for training by which postdoctoral fellows can pursue and
develop successful academic careers in clinical, translational, or basic research, creating a diverse pipeline of
investigators dedicated to improving child lung health; (2) To advance pediatric lung research through training
physician scientists and PhD scientists in the areas of (a) genetic and rare lung diseases, including interstitial
lung disease (ILD), cystic fibrosis (CF), bronchopulmonary dysplasia (BPD), and pulmonary vascular disease,
(b) lung injury, repair, and development, (c) asthma, inflammation and the environment, and (d) respiratory
physiology; and (3) To create a cohesive and collaborative environment among trainees and leading
investigators that promotes learning and cooperation across a spectrum of patient-oriented and basic
investigation, resulting in rigorous and high impact advances in respiratory health in children. The program is
committed to equal opportunity for its faculty, staff, and students and does not discriminate on the basis of any
legally protected characteristics. The proposed training program will provide 2-3 years of training in pediatric
lung-related research at the postdoctoral level for qualified candidates with an MD, MD/PhD, or DO degree
and 1-3 years of training for those with a PhD degree. We are requesting support for 4 post-doctoral
fellows/year. This training program is the result of a robust collaboration between research faculty members at
the Children’s Hospital of Philadelphia and the Perelman School of Medicine at the University of Pennsylvania.
These faculty offer mentored training in patient-oriented or basic research within the four thematic areas noted
above. The mentor-mentee relationship between research preceptor and trainee will be central to the training
experience, which will be supplemented by formal training in clinical and laboratory investigation, preparation
of grant applications, participation in a responsible conduct of research curriculum and program-wide
conferences, presentation of original research at national scientific meetings, and publication of original
research in peer-reviewed journals. Drs. Lisa Young and Sharon McGrath-Morrow are the Program Directors
and will have overall responsibility for coordination of the program, including its scientific, educational, and
administrative aspects. To support excellence in the research training of this T32 program, the Program
Directors will receive consultation from an Internal Steering Committee and an External Advisory Board. The
Children’s Hospital of Philadelphia has one of the largest and strongest pediatric pulmonary fellowship
programs in the country and is the oldest children’s hospital in the United States. The Program Directors have
trained many leaders in the field for Pediatric Pulmonology and are uniquely positioned to facilitate success
among postdoctoral trainees who will become physician scientists and researchers in pediatric lung-related
research.
项目摘要
T32儿科肺部疾病多学科培训项目的目标
费城是:(1)提供一个培训机制,使博士后研究员可以追求和
在临床,转化或基础研究方面发展成功的学术事业,创造多样化的
致力于改善儿童肺部健康的研究人员;(2)通过培训推进儿科肺部研究
(a)遗传性和罕见肺部疾病,包括间质性
肺疾病(ILD)、囊性纤维化(CF)、支气管肺发育不良(BPD)和肺血管疾病,
(b)肺损伤、修复和发育,(c)哮喘、炎症和环境,以及(d)呼吸系统
生理学;及(3)在学员及领导之间创造一个有凝聚力及合作的环境
研究人员,促进学习和合作,在一系列以病人为导向的和基本的
调查,导致儿童呼吸健康的严格和高影响的进展。该计划是
致力于为教师,员工和学生提供平等的机会,并且不基于任何歧视
受法律保护的特征。拟议的培训计划将提供2-3年的儿科培训
肺相关的研究在博士后水平的合格候选人与MD,MD/博士,或DO学位
具有博士学位的人接受1-3年的培训。我们正在申请支持4名博士后
研究员/年。该培训计划是研究教师之间的有力合作的结果,
费城儿童医院和宾夕法尼亚大学佩雷尔曼医学院。
这些教师提供指导的培训,以病人为导向或基础研究的四个主题领域内指出
以上研究导师和学员之间的导师-学员关系将是培训的核心
经验,将通过临床和实验室研究、准备
资助申请,参与研究课程和整个计划的负责任的行为
会议,在国家科学会议上介绍原创性研究,并出版原创性研究成果。
在同行评审的期刊上进行研究。丽莎杨博士和沙龙麦格拉思-莫罗是项目主任
并将全面负责该计划的协调,包括其科学,教育,
行政方面。为了支持这个T32计划的研究培训,该计划
董事将接受内部指导委员会和外部咨询委员会的咨询。的
费城儿童医院有一个最大和最强大的儿科肺奖学金
它是美国最古老的儿童医院。项目负责人有
培养了许多儿科肺病领域的领导者,并处于独特的地位,以促进成功
在博士后学员中,他们将成为儿科肺相关领域的医生科学家和研究人员,
research.
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
EBNEO Commentary: Does the effect of hydrocortisone in preterm infants depend on the baseline risk of BPD?
EBNEO 评论:氢化可的松对早产儿的影响是否取决于 BPD 的基线风险?
- DOI:10.1111/apa.16977
- 发表时间:2023
- 期刊:
- 影响因子:0
- 作者:Nelin,TimothyD;Bamat,NicolasA
- 通讯作者:Bamat,NicolasA
Inequities Faced by Children in Immigrant Families in United States NICUs.
美国新生儿重症监护室中移民家庭的儿童面临的不平等。
- DOI:10.1542/neo.25-4-e237
- 发表时间:2024
- 期刊:
- 影响因子:0
- 作者:Mercado,Osvaldo;Nelin,TimothyD;Arias-Oliveras,Ana;Montoya-Williams,Diana
- 通讯作者:Montoya-Williams,Diana
Airway clearance in patients with neuromuscular disease.
神经肌肉疾病患者的气道清除。
- DOI:10.1016/j.prrv.2023.02.002
- 发表时间:2023
- 期刊:
- 影响因子:5.8
- 作者:Gipsman,AlexanderIlan;Lapinel,NicoleChristine;Mayer,OscarHenry
- 通讯作者:Mayer,OscarHenry
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sharon Ann McGrath-Morrow其他文献
Sharon Ann McGrath-Morrow的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sharon Ann McGrath-Morrow', 18)}}的其他基金
Multidisciplinary Training Program in Pediatric Lung Diseases
小儿肺部疾病多学科培训计划
- 批准号:
10332256 - 财政年份:2022
- 资助金额:
$ 42.66万 - 项目类别:
Resolution of Diffuse Inflammatory Lung Injury in Neonatal Mice
新生小鼠弥漫性炎症性肺损伤的解决
- 批准号:
8680365 - 财政年份:2013
- 资助金额:
$ 42.66万 - 项目类别:
Resolution of Diffuse Inflammatory Lung Injury in Neonatal Mice
新生小鼠弥漫性炎症性肺损伤的解决
- 批准号:
9769845 - 财政年份:2013
- 资助金额:
$ 42.66万 - 项目类别:
Resolution of Diffuse Inflammatory Lung Injury in Neonatal Mice
新生小鼠弥漫性炎症性肺损伤的解决
- 批准号:
9613428 - 财政年份:2013
- 资助金额:
$ 42.66万 - 项目类别:
Resolution of Diffuse Inflammatory Lung Injury in Neonatal Mice
新生小鼠弥漫性炎症性肺损伤的解决
- 批准号:
10226540 - 财政年份:2013
- 资助金额:
$ 42.66万 - 项目类别:
Resolution of Diffuse Inflammatory Lung Injury in Neonatal Mice
新生小鼠弥漫性炎症性肺损伤的解决
- 批准号:
8502861 - 财政年份:2013
- 资助金额:
$ 42.66万 - 项目类别:
Resolution of Diffuse Inflammatory Lung Injury in Neonatal Mice
新生小鼠弥漫性炎症性肺损伤的解决
- 批准号:
10245317 - 财政年份:2013
- 资助金额:
$ 42.66万 - 项目类别:
NIGHTTIME HYPOXEMIA IN TEENAGERS WITH ATAXIA TELANGIECTASIA
毛细血管扩张性共济失调青少年的夜间低氧血症
- 批准号:
7604677 - 财政年份:2006
- 资助金额:
$ 42.66万 - 项目类别:
Multidisciplinary Training Program in Pediatric Pulmonary
小儿肺科多学科培训计划
- 批准号:
9068331 - 财政年份:2003
- 资助金额:
$ 42.66万 - 项目类别:
REGULATION OF GROWTH ARREST IN HYPEROXIC NEONATAL LUNG
高氧新生儿肺生长停滞的调节
- 批准号:
2027141 - 财政年份:1997
- 资助金额:
$ 42.66万 - 项目类别:
相似海外基金
Using base editing to investigate CFTR polymorphisms in lung diseases
使用碱基编辑研究肺部疾病中的 CFTR 多态性
- 批准号:
10833839 - 财政年份:2023
- 资助金额:
$ 42.66万 - 项目类别:
Bispecific immunotherapeutic delivery system for lung diseases
用于肺部疾病的双特异性免疫治疗递送系统
- 批准号:
10720773 - 财政年份:2023
- 资助金额:
$ 42.66万 - 项目类别:
Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Lung Diseases
肺生物学和肺部疾病中的干细胞、细胞疗法和生物工程
- 批准号:
10753310 - 财政年份:2023
- 资助金额:
$ 42.66万 - 项目类别:
Novel gene therapy platform for monogenetic lung diseases
单基因肺部疾病的新型基因治疗平台
- 批准号:
491900 - 财政年份:2023
- 资助金额:
$ 42.66万 - 项目类别:
Operating Grants
Exploring and Establishing Endotyping Markers in Obstructive Lung Diseases
探索和建立阻塞性肺疾病的内型标记物
- 批准号:
23K15204 - 财政年份:2023
- 资助金额:
$ 42.66万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Investigation of airway mucin expression in the distal airway and alveolar regions of interstitial lung diseases
间质性肺疾病远端气道和肺泡区气道粘蛋白表达的研究
- 批准号:
22K21371 - 财政年份:2023
- 资助金额:
$ 42.66万 - 项目类别:
Fund for the Promotion of Joint International Research (Home-Returning Researcher Development Research)
Partnerships for Research in Implementation Science for Equity in Heart and Lung diseases training program (PRISE-HL T32)
心肺疾病公平实施科学研究伙伴关系培训计划 (PRISE-HL T32)
- 批准号:
10553831 - 财政年份:2023
- 资助金额:
$ 42.66万 - 项目类别:
Complement Pathway Activation in Idiopathic Pulmonary Fibrosis and other Progressive Fibrosing Interstitial Lung Diseases
特发性肺纤维化和其他进行性纤维化间质性肺疾病中的补体途径激活
- 批准号:
10590870 - 财政年份:2023
- 资助金额:
$ 42.66万 - 项目类别:
CMKLR1-Targeted Molecular Imaging of Inflammation as a Precision Medicine Tool in Acute Lung Injury and Fibrotic Lung Diseases
CMKLR1 靶向炎症分子成像作为急性肺损伤和纤维化肺疾病的精准医学工具
- 批准号:
10733483 - 财政年份:2023
- 资助金额:
$ 42.66万 - 项目类别:
Multidisciplinary Training Program in Pediatric Lung Diseases
小儿肺部疾病多学科培训计划
- 批准号:
10332256 - 财政年份:2022
- 资助金额:
$ 42.66万 - 项目类别: